Patanjali Ayurvedic launched ‘coronil’ and ‘swasari vati’ medicine for coronavirus treatment on 23rd june 2020
Ayurvedic " Ayurveda" a form of alternative medicine . one of the world's oldest holistic healing systems
BaBa Ramdev patanjali Said that the drug accompanied by Scientific document (Tweeted on 22nd june).
A first Ayurvedic medicine for coronavirus from Haridwar, INDIA
Coronil and Swasari Vati have been developed after clinical trials and according to the company.
” we gave medicines for prevention and it was evidence based. Several corona patients tested negative they were administered our medicine we have collected clinical data of its effect on patients from different age groups. we are now going to conduct controlled clinical trials,”said Acharya Balkrishna , patanjali.Cotes by balkrishna ,ceo ,patanjali Co ltd
Trials of medicine : RESULT
It said that company has conducted a clinical case study , and found 0% death rate and 100% recovery rate has been observed, says Baba Ramdev 69% patients recovered in 3 Days while 100% patients recovered in 7 Days
He Even conduct test on people on ventilators , says baba Ramdev in the next 4-5 days , evidence and data will be released by Balkrishna .
This is not an immunity booster but a coronavirus cure, says Baba Ramdev.
The medicine has been manufactured by Haridwar’s Divya Pharmacy and Patanjali Ayurved Limited in Haridwar, based on a joint research by Patanjali Research Institute in Haridwar and the National Institute of Medical Science, Jaipur.
Madicine in Market
World want to know that when this medicine going to appear in market and how many more days it needed to available in local store and supplier.
Balkrishna says ” The corona kit will be made available at just Rs 545 ( Indian Rupees ) and within next 7 days it will available in patanjali store .
He is going to launch App for home delivery on monday 29 june 2020.
Ingridents in Medicine
Balkrishna explained that Coronil comprises of Ashwagandha, Giloy (Tinospora Cordifolia), Tulsi and Shvasari juice.
He said that Ashwagandha does not allow COVID-19’s RBD to mix with the ACE of the human body which prevents it from entering the healthy cells of the patient. He added that Giloy also works as Ashwagandha.
He said that Tulsi has also been used in the medicine which constrains the rate of coronavirus’ increase in the infected body by attacking the RNA-polymerases of attacking the RNA of the infection.
Speaking about the Shvasari juice, the Patanjali CEO said that it prevents the formation of thick mucus and reduces inflammation of the lungs by eliminating saliva.
The launch of Coronil comes at a time when anti-viral drugs Remdesivir and Favipiravir have been approved for limited use for treating COVID-19 patients in India.
After Glenmark Pharmaceuticals launched favipiravir under the brand name FabiFlu for treatment of mild to moderate cases of COVID-19, the Drug Controller General of India (DGCI) has now allowed Cipla and Hetero Labs to launch generic versions of Remdesivir under the brand names Cipremi and Covifor respectively.